Drug intelligence / Profile preview

amoxicillin + cefuroxime + clarithromycin + clavulanic acid

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

This is a combination of four antimicrobial agents: amoxicillin (a penicillin-type antibiotic), cefuroxime (a second-generation cephalosporin), clarithromycin (a macrolide antibiotic), and clavulanic acid (a beta-lactamase inhibitor that protects amoxicillin from degradation by certain bacteria). While individual components or pairs of these medications are commonly used in clinical practice, this specific four-drug combination is not a standard formulation. The individual components have different mechanisms of action against bacteria, with amoxicillin and cefuroxime targeting bacterial cell wall synthesis, clarithromycin inhibiting bacterial protein synthesis, and clavulanic acid protecting beta-lactam antibiotics from degradation by bacterial enzymes.

02

Targets

PBP (Penicillin-binding protein family)Bacterial 50S ribosomal subunitClass A BL (Class A beta-lactamase)

Beyond the preview

Go deeper on amoxicillin + cefuroxime + clarithromycin + clavulanic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amoxicillin + cefuroxime + clarithromycin + clavulanic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call